Experimental RNA vaccine trial launches for children with recurrent brain cancer
NCT ID NCT07492316
Summary
This early-stage study is testing a personalized RNA vaccine approach for children and young adults with recurrent medulloblastoma, a type of brain tumor. Researchers will create vaccines from each patient's own tumor RNA to train their immune system to fight the cancer. The main goals are to see if the vaccines can be reliably made, find the safest dose, and check for side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT MEDULLOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.